Scanned image of the page. Keyboard directions: use + to zoom in, - to zoom out, arrow keys to pan inside the viewer.

Page Options


Something wrong?

Something wrong with this page? Report problem.

Rights / Permissions

The University of Michigan Library provides access to these materials for educational and research purposes. These materials may be under copyright. If you decide to use any of these materials, you are responsible for making your own legal assessment and securing any necessary permission. If you have questions about the collection, please contact the Bentley Historical Library at bentley.ref@umich.edu

July 27, 2006 - Image 21

Resource type:
The Detroit Jewish News, 2006-07-27

Disclaimer: Computer generated plain text may have errors. Read more about this.

Do you know someone wi
Gaucher disease? This message
could be ver im ortant to the

- •

• •


• •




• •

• .

• • • .

I'm not different
because 1 have
Gaucher disease.
I'm different
because of
how 1 treat it.

- 1



Rich F: businessman,
father, beachcomber,
Zavesca patient

For adults with mild-to-moderate type 1 Gaucher disease for whom
enzyme replacement therapy is not a therapeutic option, there is an alternative.
It's an oral medicine and it's called Zavesca.

Important Safety Information: In clinical trials,

patients treated with Zavesca experienced peripheral
neuropathy, tremor, diarrhea, and weight loss.
Zavesca may also lead to birth defects if taken by
pregnant women and to impaired fertility in men.
Men and women should use effective birth control
during treatment with Zavesca.



(miglustat) capsules

To learn more, call 1-866-228-3546
or visit vvww.zavescaDT.com

Please see summary of product information on next page.

© 2006 Actelion Pharmaceuticals US, Inc. All rights reserved. ACTU ZAV JA 004 0506


July 27 2006


Back to Top

© 2021 Regents of the University of Michigan